School of Nursing, The University of Auckland, Auckland, New Zealand.
Health and Disability Sector, Spectrum Care, Auckland, New Zealand.
Australas J Ageing. 2021 Sep;40(3):e207-e214. doi: 10.1111/ajag.12900. Epub 2021 Feb 1.
To investigate medications that have the potential to be inappropriately prescribed for people with intellectual disability (ID) and to explore possible issues surrounding the potential harm that can result from the use of groups of medicines for people with ID who are ageing and living longer.
An audit of medical case records of 350 patients under the care of an organisation in New Zealand was undertaken to examine existing medication profiles.
Of the 350 patients, 95% were prescribed at least five or more medicines, with 7% of patients have 10 or more medicines. Increasing prescriptions are evident for those 56 years old and above.
Medicines that may have been appropriate for people with intellectual disability when they were younger may have the potential to cause harm when they age. It is therefore important that monitoring and evaluation of medications for ageing individuals with intellectual disability are regularly undertaken.
调查可能不适合智障人士（ID）使用的药物，并探讨随着智障人士年龄增长和寿命延长，使用某些药物可能带来的潜在危害问题。
对新西兰一家机构照护的 350 名患者的医疗病历进行审核，以检查现有药物使用情况。
350 名患者中，95%的患者至少服用 5 种或更多种药物，7%的患者服用 10 种或更多种药物。56 岁及以上患者的处方量明显增加。
对于年轻时患有智力障碍的人来说，某些药物可能是合适的，但随着年龄的增长，这些药物可能会带来潜在的危害。因此，定期监测和评估智力障碍老年患者的药物使用情况非常重要。
